LP
OACCW

LMR Partners’s Oaktree Acquisition Corp III Life Sciences Warrant OACCW Stock Holding History

LMR Partners’s Portfolio OACCW Stock Details OACCW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$71.3K Hold
95,000
– – ﹤0.01% 1283
2025
Q4 		$67.5K Hold
95,000
– – ﹤0.01% 1367
2025
Q3 		$71.3K Hold
95,000
– – ﹤0.01% 1301
2025
Q2 		$83.1K Hold
95,000
– – ﹤0.01% 1187
2025
Q1 		$71.3K Buy
+95,000
New +$72.2K ﹤0.01% 1175

Other funds holding OACCW

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $386M AUM 45.42% 1-Year Est. Return
BGIM
Boussard & Gavaudan Investment Management London, United Kingdom $1.06B AUM 4.58% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

LMR Partners's OACCW Position: Q1 2026 in Review

LMR Partners held its Oaktree Acquisition Corp III Life Sciences Warrant (OACCW) position steady in Q1 2026 at 95,000 shares worth $71.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1283.

LMR Partners first reported a position in OACCW in Q1 2025 and has held it in 5 quarters since. The position peaked at $83.1K in Q2 2025. 26 funds tracked by Wall St. Rank hold OACCW as of Q1 2026.

  • LMR Partners held 95,000 shares of Oaktree Acquisition Corp III Life Sciences Warrant worth $71.3K as of Q1 2026.
  • LMR Partners left its Oaktree Acquisition Corp III Life Sciences Warrant share count unchanged in Q1 2026.
  • Oaktree Acquisition Corp III Life Sciences Warrant made up ﹤0.01% of LMR Partners's portfolio in Q1 2026, its #1283 holding.
  • LMR Partners first reported a position in Oaktree Acquisition Corp III Life Sciences Warrant in Q1 2025 and has held it in 5 quarters since.
  • LMR Partners's Oaktree Acquisition Corp III Life Sciences Warrant position peaked at $83.1K in Q2 2025.
  • 26 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences Warrant as of Q1 2026.

Based on LMR Partners's 13F filing for Q1 2026, filed 15 May 2026.